US Patent 11571403 Methods for the treatment of non-alcoholic steatohepatitis
Patent 11571403 was granted and assigned to Eiger BioPharmaceuticals on February, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
February 4, 2020
Date of Patent
February 7, 2023
Patent Applicant
Patent Application Number
16781971
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11571403 Methods for the treatment of non-alcoholic steatohepatitis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.